Media Center

enGenes Biotech to provide ECOnti update at ICB VI continuous biomanufacturing event

Vienna, Austria: – Recombinant proteins specialist CDMO enGenes Biotech GmbH (enGenes) is returning to the 6th Integrated Continuous...

enGenes Biotech returning to CPHI Worldwide in Milan

Vienna, Austria: – Recombinant proteins specialist CDMO enGenes Biotech is returning with its advanced proprietary high-yield expression technologies to Europe’s leading pharma industry event, the CPHI Worldwide trade expo, hosted in Milan for 2024. enGenes will again attend CPHI as a visitor, with its team, including Mr. Karl Hübler, lead of the Business Development team, networking across the show. Enhanced production opportunities “We were very impressed with CPHI Worldwid

enGenes Biotech to show -excite contribution to sustainable continuous biotech production at BME 2024 in Dublin

Vienna, Austria: – Recombinant proteins specialist CDMO enGenes Biotech GmbH (enGenes) will be an active participant in the latest...

enGenes technologies deliver cost-effective, high-yield bioprocesses over broad range of for specific Applications

enGenes Biotech has developed a suite of patented technology platforms for the customized production of recombinant proteins, enzymes,...

enGenes Biotech Team participates at Vienna City Marathon 2024

Vienna, Austria: As of the Sunday 21st April 2024 has the team of enGenes Biotech, Vienna based Biotech company, participated at the...

enGenes Biotech Launches Its New Website

Vienna, Austria: – Recombinant proteins specialist CDMO enGenes Biotech GmbH (enGenes) now has a fresh and more comprehensive web...

enGenes Biotech’s continuous microbial protein expression and purification

enGenes Biotech is implementing upgrades to its processes and equipment that will allow it to offer continuous recombinant protein...

enGenes Biotech bringing advanced protein expression offers to Bio-Europe Munich

Vienna, Austria: – Recombinant proteins specialist CDMO enGenes Biotech GmbH (enGenes) will again participate in Europe’s flagship life sciences partnering conference, BIO-Europe 2023, this year in Munich. enGenes team will take part in the event’s extensive networking platform, to promote the company’s advanced proprietary high yield expression technologies. Leading edge protein expression The enGenes team will be ready to communicate the technological advantages of its pla

enGenes announce attendance to Recombinant Protein Production (RPP) conference in Girona, Spain

Girona, Spain: – enGenes Biotech GmbH (enGenes) will attend the Recombinant Protein Production (RPP) conference from the 17th – 19th...

enGenes Biotech to make CPHI debut in Barcelona

Vienna, Austria: – Recombinant proteins specialist CDMO enGenes Biotech GmbH (enGenes) will attend Europe’s leading pharma industry event, the CPHI 2023 trade expo, this year in Barcelona, to promote its advanced proprietary high yield expression technologies. On its first appearance at CPHI, enGenes will attend as a visitor, sending a team led by its CEO and co-founder Dr. Jürgen Mairhofer to take part in networking activities. Leading edge protein expression Dr. Mairhofer